Page last updated: 2024-10-25

diazoxide and Nephrosclerosis

diazoxide has been researched along with Nephrosclerosis in 3 studies

Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Nephrosclerosis: Hardening of the KIDNEY due to infiltration by fibrous connective tissue (FIBROSIS), usually caused by renovascular diseases or chronic HYPERTENSION. Nephrosclerosis leads to renal ISCHEMIA.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vaziri, ND1
Mroczek, WJ1
Fillastre, JP1
Malandain, M1
Gray, H1
Dubois, D1

Reviews

2 reviews available for diazoxide and Nephrosclerosis

ArticleYear
Malignant or accelerated hypertension.
    The Western journal of medicine, 1984, Volume: 140, Issue:4

    Topics: Blood Coagulation Disorders; Brain Diseases; Diazoxide; Glomerulosclerosis, Focal Segmental; Humans;

1984
Malignant hypertension: kidneys too good to be extirpated.
    Annals of internal medicine, 1974, Volume: 80, Issue:6

    Topics: Animals; Blood Pressure; Diazoxide; Furosemide; Glomerulonephritis; Humans; Hypertension, Malignant;

1974

Other Studies

1 other study available for diazoxide and Nephrosclerosis

ArticleYear
[Treatment of malignant nephroangiosclerosis with diazoxide].
    La Nouvelle presse medicale, 1972, Nov-11, Volume: 1, Issue:40

    Topics: Diazoxide; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension, Malignant; Injections, Int

1972